Metabolic syndrome in Overt and Subclinical Hypothyroidism Syrian Patients
Abstract
Thyroid hormones play an important role in several metabolic pathways including glucose and lipid metabolism and may cause metabolic syndrome. Both hypothyroidism and metabolic syndrome are common in Syrian population. This study was done to evaluate the metabolic syndrome in two types of hypothyroidism and the effect of TSH levels on its occurrence. A retrospective cross-sectional study was performed of 91 patients with overt hypothyroidism, 31 patients with subclinical hypothyroidism without clinical symptoms and 53 controls without thyroid disorders. Metabolic syndrome was defined as per International Diabetes Federation(IDF) criteria which are defined as central obesity based on race- and gender-specific WC cutoffs (Waist circumference (WC) ≥ 94cm for male , WC ≥ 80cm for female) plus
any two of the following four parameters: (Raised triglycerides: ≥150 mg/dl (1.7 mmol/l) or history of specific treatment for this lipid abnormality, Reduced HDL cholesterol: < 40 mg/dl (1.03 mmol/l) in males and < 50 mg/dl (1.29 mmol/l) in females or history of specific treatment for this lipid abnormality, Raised blood pressure: systolic BP ≥130 mm Hg or diastolic BP ≥85 mm Hg or on treatment for previously diagnosed hypertension and Raised FPG: ≥ 100 mg/dl or previously diagnosed type 2 Diabetes mellitus
In conclusion, our study showed significant association between overt hypothyroidism and metabolic syndrome. It also revealed that TSH level over 2.5 uIU/ml significantly increases the risk of the metabolic syndrome.
2-Chakrabarti SK, Ghosh S, Banerjee S, Mukherjee S, Chowdhury S. Oxidative stress in hypothyroid patients and the role of antioxidant supplementation. Indian journal of endocrinology and metabolism. 2016;20(5):674-8.
3- Duntas LH, Brenta G. A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism. Frontiers in endocrinology. 2018;9:511.
4- Wang C. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. Journal of diabetes research. 2013;2013:390534.
5-Yoon, Y. S.Lee, E. S.Park, C.Lee, S.Oh, S. W. The new definition of Metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes (Lond).2007: 528-34.
6- Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation. 2009;120(16):1640–1645.
7- Alberti KGMM, Zimmet P. The metabolic syndrome—a new worldwide definition. The Lancet. 2005;366(9491):1059–1062.
8-Parikh RM, Mohan V. Changing definitions of metabolic syndrome. Indian journal of endocrinology and metabolism. 2012;16(1):7-12.
9- Biondi B , Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev . 2008;29:76–131.
10- Fatourechi V. Subclinical hypothyroidism: an updatefor primary care physicians. Mayo Clinic proceedings.2009;84(1):65-71.
11- Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. Journal of thyroid research.2011;2011:439-463.
12- Walsh JP , Bremner AP , Feddema P , Leedman PJ , Brown SJ , O'Leary P 2010 Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 95:1095–1104.
13- Lai Y, Wang J, Jiang F, Wang B, Chen Y, Li M, Liu H, Li C, Xue H, Li N, Yu J, Shi L, Bai X, Hou X, Zhu L, Lu L, Wang S, Xing Q, Teng X, Teng W, Shan Z, Endocr J. The relationship between serum thyrotropin and components of metabolic syndrome. Department of Endocrinology and Metabolism. 2011; 58(1):23-30.
14- Iwen KA, Schroder E, Brabant G. Thyroid hormones and the metabolic syndrome. European thyroid journal. 2013;2(2):83-92.
15- Gessl A, Lemmens-Gruber R, Kautzky-Willer A.Thyroid disorders. Handbook of experimental pharmacology. 2012(214):361-86.
Files | ||
Issue | Vol 60, No 2 (2022) | |
Section | Original Article(s) | |
DOI | https://doi.org/10.18502/acta.v60i2.8822 | |
Keywords | ||
Overt hypothyroidism Subclinical hypothyroidism Metabolic syndrome Thyroid-stimulating hormone Obesity |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |